Cargando…
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
Autores principales: | Diamond, Eli L., Francis, Jasmine H., Lacouture, Mario E., Rotemberg, Veronica, Yabe, Mariko, Petrova-Drus, Kseniya, Ulaner, Gary A., Reddy, Ryan, Abdel-Wahab, Omar, Durham, Benjamin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400417/ https://www.ncbi.nlm.nih.gov/pubmed/37355734 http://dx.doi.org/10.1038/s41375-023-01947-4 |
Ejemplares similares
-
Efficacy of MEK Inhibition in Patients with Histiocytic Neoplasms
por: Diamond, Eli L., et al.
Publicado: (2019) -
Activating mutations in CSF-1R and additional receptor tyrosine kinases in histiocytic neoplasms
por: Durham, Benjamin H., et al.
Publicado: (2019) -
Spontaneous fibrous histiocytic neoplasms in rats.
por: Greaves, P., et al.
Publicado: (1981) -
Histiocytic and dendritic cell neoplasms of the mediastinum
por: Baraban, Ezra, et al.
Publicado: (2020) -
Prognostic factors for histiocytic and dendritic cell neoplasms
por: Shimono, Joji, et al.
Publicado: (2017)